IPP Bureau
OncoSil secures TGA approval for pancreatic cancer device
By IPP Bureau - May 22, 2026
Approval of device in Australia for treating locally advanced pancreatic cancer alongside gemcitabine-based chemotherapy
Eli Lilly appoints Chandan S. as Senior Director for Data Science and AI Engineering
By IPP Bureau - May 22, 2026
AI and analytics leader brings extensive expertise in machine learning, GenAI, and life sciences decision intelligence to Lilly’s data science operations
Alembic Pharma elevates Karunanithi Ponnusamy as President of Animal Health Business
By IPP Bureau - May 22, 2026
Pharma veteran with over three decades of industry experience to lead Alembic’s animal health growth and market expansion initiatives.
Reliance Life Sciences appoints Siva Sankar Mahamkali as VP Biosimilars Manufacturing Operations
By IPP Bureau - May 22, 2026
Biologics manufacturing veteran brings over two decades of expertise in biosimilars, GMP operations, and large-scale biopharmaceutical manufacturing
Dr. Amit Arora joins Curelo as Co-founder & COO
By IPP Bureau - May 22, 2026
Diagnostic-guided healthcare platform strengthens leadership team to accelerate AI-driven diagnostics and consumer healthcare expansion
Aurobindo Pharma Q4 FY26 revenue rises 5.6% to Rs. 8,853 crore
By IPP Bureau - May 22, 2026
Net profit stood at Rs. 921 crore for the quarter, while Europe revenues surged 30.2% YoY to Rs. 2,795 crore
Dr. Agarwal’s crosses Rs. 2,000 crore revenue milestone in FY26
By IPP Bureau - May 22, 2026
Eye care major expands network to 288 facilities across 10 countries after adding 57 new centres during FY26
Venus Remedies secures global approval for Plerixafor in Saudi Arabia
By IPP Bureau - May 22, 2026
SFDA nod marks company’s strategic entry into high-value specialty oncology injectables as it targets expanding stem cell transplant and haemato-oncology market in the GCC region
Alembic Pharma receives USFDA nod for generic Levothyroxine sodium tablets
By IPP Bureau - May 22, 2026
Approved product is therapeutically equivalent to Synthroid of AbbVie and is indicated for the treatment of congenital or acquired hypothyroidism
Lupin enters China market with approval for Oseltamivir oral suspension
By IPP Bureau - May 22, 2026
The approval has been secured in partnership with Yabao Pharmaceuticals, a major player in China’s paediatric medicine segment
Sun Pharma reports FY26 revenue of Rs. 58,220 crore, net profit at Rs. 11,479 crore
By IPP Bureau - May 22, 2026
Q4FY26 revenue rises 13.6% to Rs. 14,560 crore; quarterly net profit jumps 26.2% to Rs. 2,714 crore driven by India business and Innovative Medicines growth
Jubilant Pharmova posts FY26 revenue of Rs. 8,280 crore, up 14%
By IPP Bureau - May 22, 2026
Q4FY26 revenue climbs 19% to Rs. 2,290 crore as CDMO sterile injectables, radiopharma and generics businesses drive growth momentum
APHI welcomes CCI order on integrated healthcare delivery model
By IPP Bureau - May 22, 2026
The ruling brings closure to a nearly decade-long investigation into hospital operations and healthcare delivery practices
IOLCP revenue rises 11.5% YoY to Rs. 2,319.1 crore in FY26
By IPP Bureau - May 21, 2026
Company’s EBITDA grew 29.3 per cent to Rs. 290.4 crore, while PAT rose 36.4 per cent to Rs. 137.7 crore
Takeda Pharma ordered to pay $2.5 billion in Amitiza case
By IPP Bureau - May 21, 2026
US federal jury finds Japanese drugmaker liable for anticompetitive agreement delaying generic version of constipation drug Amitiza
